Next Generation GMP Facility For CRISPR Based Therapies
Source: Synthego Corporation
As CRISPR based Cell & Gene therapies continue to transition into the clinic, next generation facilities could help those therapies along. Explore this Synthego tour of their state-of-the-art GMP facility, including a temperature controlled warehouse and multiple synthesis suites. Learn how the facility is aiding Synthego in providing CRISPR expertise to customers.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.
Subscribe to Advancing RNA
X
Subscribe to Advancing RNA
Synthego Corporation
This website uses cookies to ensure you get the best experience on our website. Learn more